Roberto De Ponti PharmD
Managing Director and General Partner
Roberto is Managing Director and General Partner. Prior to this, Roberto was Head of Corporate Business Development at Helsinn. Roberto has held several Senior Director positions in various pharmaceutical companies including Pfizer, Indena, Pharmacia & Upjohn, Nerviano Medical Sciences and Boehringer Mannheim. His extensive background in the pharmaceutical industry includes the development of blockbuster drugs, oversight of R&D and manufacturing as well as licensing and business development. Roberto is on the board of several portfolio companies in Europe and the US. He holds a PharmD degree and is an EU Qualified Person.
Roberto serves on the board of OncoResponse, Domain Therapeutics, Roca Therapeutics, Fore and is an observer on the board of iOnctura and Epsilogen.
Our Team
Paolo Paoletti MD
Strategic Advisor
Alessandro Santoboni
Investment Analyst
Carlos von Bonhorst MD
Strategic Advisor
Riccardo Braglia MBA
Chairman and General Partner
Francesco Granata MD
Strategic Advisor and General Partner
Roberto De Ponti PharmD
Managing Director and General Partner
Francesco Giavatto MBA
Chief Financial Officer and General Partner
Karin Hehenberger MD, PhD
Strategic Advisor
Marianne Bjordal PhD, MBA
General Partner
Sandra van Essche JD
Corporate Affairs Advisor
Stefano Coco MSc
Associate
Get in touch
Thank you for your form submission, we will get in contact with you shortly.
